SLGL (Sol-Gel Technologies) EPS without NRI: $-0.33 (TTM As of Mar. 2026)


SLGL Sol-Gel Technologies Ltd SLGL
55 GF Score
Price $73.74
GF Value $65.37
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies EPS without NRI?

Sol-Gel Technologies SLGL -0.88% 55 EPS without NRI is $-0.33 as of Mar. 2026. GuruFocus rates SLGL with a GF Score™ of 55/100 and a GF Value™ of $65.37 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 1,172 Biotechnology companies, Sol-Gel Technologies ranks better than 66.13% on this metric.

Sol-Gel Technologies's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-1.31. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.33.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 30.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Sol-Gel Technologies's EPS without NRI or its related term are showing as below:

SLGL' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -49.6   Med: 8.9   Max: 30.4
Current: 30.4

During the past 11 years, Sol-Gel Technologies's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 30.40% per year. The lowest was -49.60% per year. And the median was 8.90% per year.

SLGL's 3-Year EPS without NRI Growth Rate is ranked better than
66.13% of 1172 companies
in the Biotechnology industry
Industry Median: 16.8 vs SLGL: 30.40

Sol-Gel Technologies's EPS (Diluted) for the three months ended in Mar. 2026 was $-1.31. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.33.

Sol-Gel Technologies's EPS (Basic) for the three months ended in Mar. 2026 was $-1.31. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.33.


Sol-Gel Technologies  (NAS:SLGL) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sol-Gel Technologies EPS without NRI Related Terms


Sol-Gel Technologies EPS without NRI Historical Data

* Premium members only.

The historical data trend for Sol-Gel Technologies's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sol-Gel Technologies EPS without NRI Chart

Sol-Gel Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 -6.50 -10.01 -3.79 -2.19

Sol-Gel Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.20 4.17 -2.13 -1.06 -1.31

SLGL vs AVXL, FATE, FHTX: EPS without NRI Comparison

For the Biotechnology subindustry, Sol-Gel Technologies's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sol-Gel Technologies PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sol-Gel Technologies's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Sol-Gel Technologies's PE Ratio without NRI falls into.


SLGL
55GF Score
Sol-Gel Technologies Ltd SLGL
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sol-Gel Technologies EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.33 mean?
Sol-Gel Technologies (SLGL) has a EPS without NRI of $-0.33 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sol-Gel Technologies and its competitors. According to the industry distribution chart, Sol-Gel Technologies ranks #397 out of 1172 companies in the Biotechnology industry, placing it in the top 33.9%.
Is Sol-Gel Technologies' EPS without NRI too high?
Sol-Gel Technologies' current EPS without NRI is $-0.33. Based on the distribution chart, Sol-Gel Technologies ranks #397 out of 1172 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sol-Gel Technologies has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sol-Gel Technologies' EPS without NRI compare to AVXL and FATE?
According to the Biotechnology industry distribution chart, Sol-Gel Technologies ranks #397 out of 1172 companies for EPS without NRI. This puts Sol-Gel Technologies in the upper half of its industry. The industry median EPS without NRI is 16.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.80, based on 1,172 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sol-Gel Technologies and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sol-Gel Technologies's current EPS without NRI is $-0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sol-Gel Technologies stock overvalued right now?
Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $65.37, compared to a current price of $73.74 — trading 12.8% above its estimated fair value. The current EPS without NRI is $-0.33. Sol-Gel Technologies' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current EPS without NRI is $-0.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $73.74 is trading 12.8% above its estimated GF Value™ of $65.37. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for SLGL:

  • EPS without NRI: $-0.33
  • GF Value™: $65.37 vs. price of $73.74 (12.8% above fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sol-Gel Technologies Business Description

Other Exchanges 4SG:Germany
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
55GF Score

Get the complete analysis for SLGL

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.74
Price
$65.37
GF Value